This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.
Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri: Key Facts & Context
Detailed background, context, and analysis on this topic, compiled for open research purposes.
Reference: U.S. Food and Drug Administration (FDA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.